Transfection
: Whole inner ears were dissected from C57Bl/6 mice and utricles were removed. The utricles were placed on a 0.45-µm Millicell-HA culture insert (cat# PIHA01250) in a 24-well plate with media (DMEM, N1 supplement, penicillin, neomycin 10
−3). This process was repeated for each subsequent dissection. The tissues were incubated for 48 h at 37°C/5% CO
2 to induce injury. The vector was added to fresh media (1 µl vector/400 µl medium) into a new 24-well plate and returned to the incubator. The medium was collected and replaced every 72 h ending on the 27th day of collection. The media were then placed in −20°C freezer until further analysis. Analysis was performed in triplicate with five utricles per membrane.
Enzyme-linked immunosorbent assay (ELISA): ELISAs specific for BDNF and NT-3 were used to detect expression levels in the supernatants. Explant supernatant was thawed, and reactivity was tested for the neurotrophins (BDNF: PicoKine
™ ELISA Kit, Boster Biological Technology #EK0307/9; NT-3:
mouse Neurotrophin-3 ELISA Kit, Abcam, ab213882).
A subset of neomycin medium collected from neomycin-treated explants which were incubated with Ad28.lat.bdnf were microdialyzed using Pall Nanosep
® Filters (Pall Corp, Westborough, MA United States) per manufacturer’s instructions and subsequently assayed for BDNF content as outlined above.
St. Peter M., Brough D.E., Lawrence A., Nelson-Brantley J., Huang P., Harre J., Warnecke A, & Staecker H. (2022). Improving Control of Gene Therapy-Based Neurotrophin Delivery for Inner Ear Applications. Frontiers in Bioengineering and Biotechnology, 10, 892969.